Baseline Characteristics Module

Baseline Characteristics Module

The Baseline Characteristics Module provides demographic and baseline characteristics information for participants in a clinical trial. This module includes data such as population descriptions and the types of units analyzed, helping researchers understand the baseline characteristics of study participants.

Baseline Characteristics Module path is as follows:

Study -> Results Section -> Baseline Characteristics Module

Baseline Characteristics Module


Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2025-12-26 @ 2:21 AM
NCT ID: NCT05328102
Population Description: Enrolled Analysis Set: All participants who signed the informed consent form, were determined to be eligible, and received Day -8 tafasitamab dose (Study Day 1). The study was terminated by the Sponsor during Part 1A of the study. No participants were enrolled in Part 1B or Part 2.
Study: NCT05328102
Study Brief:
Results Section: NCT05328102